Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Acorda Therapeutics 401(K) Plan is a benefit plan reported by Acorda Therapeutics, Inc. under EIN 13-3831168 and plan number 001. The latest loaded filing year is 2023. The filing reports 333 participants and $64,865,286 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $64,865,286
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $64,865,286
- Net assets (BOY)
- $60,192,826
Income & contributions
- Employer contributions
- $645,448
- Participant contributions
- $2,239,036
- Total contributions
- $2,923,635
- Total income / additions
- $13,321,960
Expenses & distributions
- Benefits paid
- $8,603,589
- Administrative expenses
- $45,911
- Total expenses
- $8,649,500
- Net increase / (decrease)
- $4,672,460